Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
about
A 3'-UTR Polymorphism in Soluble Epoxide Hydrolase Gene Is Associated with Acute Rejection in Renal Transplant RecipientsShort-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients.Association between insulin resistance and endothelial dysfunction in renal transplant recipients.Surgical biology for the clinician: vascular effects of immunosuppressionPathogenesis of calcineurin inhibitor-induced hypertensionEndothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplantAbnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activationSoluble TWEAK independently predicts atherosclerosis in renal transplant patients.Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.Relationship between Plasma Pentraxin-3, Neutrophil-to-Lymphocyte Ratio, and Atherosclerosis in Renal Transplant Patients.Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.Beta and angiotensin blockades are associated with improved 10-year survival in renal transplant recipients.An interleukin-6-neutralizing antibody prevents cyclosporine-induced nephrotoxicity in mice.Calcineurin-mediated dephosphorylation of eNOS at serine 116 affects eNOS enzymatic activity indirectly by facilitating c-Src binding and tyrosine 83 phosphorylation.The management of hypertensive emergencies in children after stem cell transplantation.Cardiovascular disease in chronic kidney disease: untying the Gordian knot.Asymmetric dimethylarginine, endothelial dysfunction and renal diseaseHypertension after kidney transplantation: a pathophysiologic approach.Graft microvascular disease in solid organ transplantation.Penile transplantation: an emerging option for genitourinary reconstruction.Cyclosporine A-induced nitration of tyrosine 34 MnSOD in endothelial cells: role of mitochondrial superoxide.Differential effects of cyclosporine and tacrolimus on arterial function.Role of penile vascular insufficiency in erectile dysfunction in renal transplant recipients.Circulating endothelial cells in pediatric renal transplant recipients.The effect of calcineurin inhibitors on endothelial function in renal transplant recipients.Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction.Protective effect of curcumin on cyclosporin A-induced endothelial dysfunction, antioxidant capacity, and oxidative damage.Circulating Angiopoietin-2 levels predict mortality in kidney transplant recipients: a 4-year prospective case-cohort study.Blood pressure measurements, blood pressure variability and endothelial function in renal transplant recipients.The arginine-creatine pathway is disturbed in children and adolescents with renal transplants.Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction.Alpha-tocopherol and alpha-lipoic acid enhance the erythrocyte antioxidant defence in cyclosporine A-treated rats.Critical evaluation of the factors influencing erectile function after renal transplantation.Pyridoxine Deficiency After Solid Organ Transplant.The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients.Longitudinal Analysis of Vascular Function and Biomarkers of Metabolic Bone Disorders before and after Renal TransplantationHypertension: The Neglected Complication of Transplantation
P2860
Q28384776-CEA95D46-F42A-473F-9DC6-90192B3629FEQ33210296-86164EFA-6836-47ED-8E3D-4D993237EACFQ33241175-6F997D41-B78D-408F-80B2-B5E9D2E08BDEQ33604754-C49CC12B-8A98-40B4-8808-3AE951B1628CQ33723923-7B80F74E-3128-44E3-9D51-8F31B6A2ECF0Q34098493-445551B4-C8A2-4B87-BD68-8CD5E847B11DQ34249903-DA948E11-B3A5-43FF-9C3F-DDE6ECFD71C3Q34815993-D4907A6A-7266-4123-84A8-26E73F01B2FEQ36073213-CE2A8C40-C20C-4834-BE2E-F5A2FB2C8390Q36551416-E77EAAD3-C69A-4EFF-B2B2-FE38C9E30667Q36686822-0FED2673-293E-4782-89CB-0A0BC8342EA3Q36701855-4E9BBE8E-F02E-4C50-95B0-79E97901AA79Q36877232-9F458EF0-9434-4C95-923A-BCB342FEE3E8Q37299501-E0B4FBA4-5A0E-4E27-AD3A-7D8FA7747409Q37851883-FAC9BA8A-B710-4BD4-9933-7542651F1B5CQ38025185-9CCD6CF7-9C23-482A-A2A2-4D0B201F0DD1Q38056493-27CE4A4B-2469-4747-A6B9-DADB62A847C4Q38128162-930CB4F3-78F2-49D0-A99D-06B928D76E98Q38216381-76997A6D-1DD9-4ADF-A9EE-2B52EF195079Q39107341-F7D30BAE-C3E5-468E-914F-EEF0E91A547FQ43182602-4E60C960-9B8A-4497-BE35-12F696C597BDQ43698706-55F2A40B-D6E6-4076-86C7-6E712AA722E4Q43918996-DBC293E1-30FA-402A-9083-857CCA2A13D9Q44118585-38C91529-7497-48F6-AA3C-7E8E4A05E6A8Q44461522-417DF229-E0AB-4A98-A914-29530AE43161Q44471173-1A5A63B6-AD17-4AD3-82FD-BD749E37550EQ45272269-1D53F9EF-5404-40BE-97AD-0E6C537CFE97Q45959076-DFA6A4F4-C260-4002-9A64-5203694D51B2Q46084842-67A77BC7-71FC-48EB-B559-0FEB94ACED88Q46662055-BD026ABE-EB78-4D5A-8A19-8BD7ABF6DA63Q46909261-576EA640-CF10-427C-952A-17812E8D61A2Q46909432-3F95E0A8-1C59-43CB-B64D-A3F5786584ACQ47929634-DA267A48-98E0-4F5A-B34B-0D707E5D62BBQ49544446-902E0A41-AA2F-4665-B3A0-C68B057F6275Q50922246-5CB12FCD-372A-45FC-B4B9-50EF13B89383Q58946285-866FC223-BCD8-46D3-9485-6AB2FFEC8851Q58992876-A6FF7172-56BB-4132-987D-11B57D0C9897
P2860
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
@ast
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
@en
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
@nl
type
label
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
@ast
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
@en
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
@nl
prefLabel
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
@ast
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
@en
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
@nl
P2093
P1433
P1476
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
@en
P2093
J J McMurray
R S Rodger
S T Morris
P304
P356
10.1046/J.1523-1755.2000.00937.X
P407
P50
P577
2000-03-01T00:00:00Z
P5875
P6179
1015114728